Úplné zobrazení záznamu

Toto je statický export z katalogu ze dne 19.12.2020. Zobrazit aktuální podobu v katalogu.

Bibliografická citace

.
0 (hodnocen0 x )
BK
Revised 4th edition
Lyon : International Agency for Research on Cancer, 2016
408 stran : barevné ilustrace ; 27 cm

objednat
ISBN 978-92-832-4492-9 (brožováno)
World Health Organization classification of tumours
Nad názvem: WHO, OMS, International Agency for Research on Cancer (IARC)
Obsahuje bibliografii na stranách 356-401 a rejstřík
001484730
Contents // WHO classification 10 // Introduction: WHO classification and grading of tumours // of the central nervous system 12 // 1 Diffuse astrocytic and oligodendroglial tumours 15 // Introduction 16 // Diffuse astrocytoma, IDH-mutant 18 // Gemistocytic astrocytoma, I DH-mutant 22 // Diffuse astrocytoma, IDH-wildtype 23 // Diffuse astrocytoma, NOS 23 // Anaplastic astrocytoma, I DH-mutant 24 // Anaplastic astrocytoma, IDH-wildtype 27 // Anaplastic astrocytoma, NOS 27 // Glioblastoma, IDH-wildtype 28 // Giant cell glioblastoma 46 // Gliosarcoma 48 // Epithelioid glioblastoma 50 // Glioblastoma, IDH-mutant 52 // Glioblastoma, NOS 56 // Diffuse midline glioma, H3 K27M-mutant 57 // Oligodendroglioma, IDH-mutant and 1p/19q-codeleted 60 // Oligodendroglioma, NOS 69 // Anaplastic oligodendroglioma, IDH-mutant and // 1p/19q-codeleted 70 // Anaplastic oligodendroglioma, NOS 74 // Oligoastrocytoma, NOS 75 // Anaplastic oligoastrocytoma, NOS 76 // 2 Other astrocytic tumours 79 // Pilocytic astrocytoma 80 // Pilomyxoid astrocytoma 88 // Subependymal giant cell astrocytoma 90 // Pleomorphic xanthoastrocytoma 94 // Anaplastic pleomorphic xanthoastrocytoma 98 // 3 Ependymal tumours 101 // Subependymoma 102 // Myxopapillary ependymoma 104 // Ependymoma 106 // Papillary ependymoma 111 // Clear cell ependymoma 111 // Tanycytic ependymoma 111 // Ependymoma, ??? fusion-positive 112 // Anaplastic ependymoma 113 // 4 Other gliomas 115 // Chordoid glioma of the third ventricle 116 // Angiocentric
glioma 119 // Astroblastoma 121 // 5 Choroid plexus tumours 123 // Choroid plexus papilloma 124 // Atypical choroid plexus papilloma 126 // Choroid plexus carcinoma 128 // 6 Neuronal and mixed neuronal-glial tumours 131 // Dysembryoplastic neuroepithelial tumour 132 // Gangliocytoma 136 // Ganglioglioma 138 // Anaplastic ganglioglioma 141 // Dysplastic cerebellar gangliocytoma // (Lhermitte-Duclos disease) 142 // Desmoplastic infantile astrocytoma and ganglioglioma 144 // Papillary glioneuronal tumour 147 // Rosette-forming glioneuronal tumour 150 // Diffuse leptomeningeal glioneuronal tumour 152 // Central neurocytoma 156 // Extraventricular neurocytoma 159 // Cerebellar liponeurocytoma 161 // Paraganglioma 164 // 7 Tumours of the pineal region 169 // Pineocytoma 170 // Pineal parenchymal tumour of intermediate differentiation 173 Pineoblastoma 176 // Papillary tumour of the pineal region 180 // 8 Embryonal tumours 183 // Medulloblastoma 184 // Medulloblastoma, NOS 186 // Medulloblastomas, genetically defined 188 // Medulloblastoma, WNT-activated 188 // Medulloblastoma, SHH-activated and 7P53-mutant 190 // Medulloblastoma, SHH-activated and 7P53-wildtype 190 Medulloblastoma, non-WNT/non-SHH 193 // Medulloblastomas, histologically defined 194 // Medulloblastoma, classic 194 // Desmoplastic/nodular medulloblastoma 195 // Medulloblastoma with extensive nodularity 198 // Large cell / anaplastic medulloblastoma 200 // Embryonal tumour with multilayered rosettes, // C19MC-altered 201
// Embryonal tumour with multilayered rosettes, NOS 205 // Other CNS embryonal tumours 206 // Medulloepithelioma 207 // CNS neuroblastoma 207 // CNS ganglioneuroblastoma 207 // CNS embryonal tumour, NOS 208 // Atypical teratoid/rhabdoid tumour 209 // CNS embryonal tumour with rhabdoid features 212 // 9 Tumours of the cranial and paraspinal nerves 213 // Schwannoma 214 // Cellular schwannoma 216 // Plexiform schwannoma 217 // Melanotic schwannoma 218 // Neurofibroma 219 // Atypical neurofibroma 220 // Plexiform neurofibroma 220 // Perineurioma 222 // Hybrid nerve sheath tumours 224 // Malignant peripheral nerve sheath tumour (MPNST) 226 // MPNST with divergent differentiation 227 // Epithelioid MPNST 228 // MPNST with perineurial differentiation 228 // 10 Meningiomas 231 // Meningioma 232 // Meningioma variants 237 // Meningothelial meningioma 237 // Fibrous meningioma 237 // Transitional meningioma 238 // Psammomatous meningioma 238 // Angiomatous meningioma 238 // Microcystic meningioma 239 // Secretory meningioma 239 // Lymphoplasmacyte-rich meningioma 240 // Metaplastic meningioma 240 // Chordoid meningioma 240 // Clear cell meningioma 241 // Atypical meningioma 241 // Papillary meningioma 242 // Rhabdoid meningioma 243 // Anaplastic (malignant) meningioma 244 // 11 Mesenchymal, non-meningothelial tumours 247 // Solitary fibrous tumour / haemangiopericytoma 249 // Haemangioblastoma 254 // Haemangioma 258 // Epithelioid haemangioendothelioma 258 // Angiosarcoma 259 // Kaposi
sarcoma 259 // Ewing sarcoma / peripheral primitive // neuroectodermal tumour 259 // Lipoma 260 // Angiolipoma 260 // Hibernoma 260 // Liposarcoma 260 // Desmoid-type fibromatosis 260 // Myofibroblastoma 260 // Inflammatory myofibroblastic tumour 261 // Benign fibrous histiocytoma 261 // Fibrosarcoma 261 // Undifferentiated pleomorphic sarcoma / malignant // fibrous histiocytoma 261 // Leiomyoma 262 // Leiomyosarcoma 262 // Rhabdomyoma 262 // Rhabdomyosarcoma 262 // Chondroma 262 // Chondrosarcoma 263 // Osteoma 264 // Osteochondroma 264 // Osteosarcoma 264 // 12 Melanocytic tumours 265 // Meningeal melanocytosis 267 // Meningeal melanomatosis 267 // Meningeal melanocytoma 268 // Meningeal melanoma 269 // 13 Lymphomas 271 // Diffuse large ?-cell lymphoma of the CNS 272 // Corticoid-mitigated lymphoma 275 // Sentinel lesions 275 // Immunodeficiency-associated CNS lymphomas 275 // AIDS-related diffuse large ?-cell lymphoma 275 // EBV+ diffuse large ?-cell lymphoma, NOS 276 // Lymphomatoid granulomatosis 276 // Intravascular large ?-cell lymphoma 276 // Miscellaneous rare lymphomas in the CNS 276 // Low-grade ?-cell lymphomas 276 // T-cell and NK/T-cell lymphomas 276 // Anaplastic large cell lymphoma (ALK+/ALK-) 277 // MALT lymphoma of the dura 277 // 14 Histiocytic tumours 279 // Langerhans cell histiocytosis 280 // Erdheim-Chester disease 281 // Rosai-Dorfman disease 282 // Juvenile xanthogranuloma 282 // Histiocytic sarcoma 283 // 15 Germ cell tumours 285 // Germinoma 288 // Embryonal
carcinoma 289 // Yolk sac tumour 290 // Choriocarcinoma 290 // Teratoma 291 // Mature teratoma 291 // Immature teratoma 291 // Teratoma with malignant transformation 291 // Mixed germ cell tumour 291 // 16 Familial tumour syndromes 293 // Neurofibromatosis type 1 294 // Neurofibromatosis type 2 297 // Schwannomatosis 301 // Von Hippel-Lindau disease 304 // Tuberous sclerosis 306 // Li-Fraumeni syndrome 310 // Cowden syndrome 314 // Turcot syndrome 317 // Mismatch repair cancer syndrome 317 // Familial adenomatous polyposis 318 // Naevoid basal cell carcinoma syndrome 319 // Rhabdoid tumour predisposition syndrome 321 // 17 Tumours of the sellar region 323 // Craniopharyngioma 324 // Adamantinomatous craniopharyngioma 327 // Papillary craniopharyngioma 328 // Granular cell tumour of the sellar region 329 // Pituicytoma 332 // Spindle cell oncocytoma 334 // 18 Metastatic tumours 337 // Contributors 342 // Declaration of interest statements 349 // IARC/WHO Committee for ICD-0 350 // Sources of figures and tables 351 // References 356 // Subject index 402 // List of abbreviations 408

Zvolte formát: Standardní formát Katalogizační záznam Zkrácený záznam S textovými návěštími S kódy polí MARC